BioLife Solutions
BLFS
169 hedge funds and large institutions have $850M invested in BioLife Solutions in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 62 increasing their positions, 48 reducing their positions, and 13 closing their positions.
552% more call options, than puts
Call options by funds: $411K | Put options by funds: $63K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
29% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 48
23% more capital invested
Capital invested by funds: $690M → $850M (+$160M)
3% more funds holding
Funds holding: 164 → 169 (+5)
2.06% more ownership
Funds ownership: 88.61% → 90.67% (+2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$11.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.98M |
| 3 |
BCIM
British Columbia Investment Management
Victoria,
British Columbia, Canada
|
+$2.42M |
| 4 |
GS
Gagnon Securities
New York
|
+$2M |
| 5 |
Morgan Stanley
New York
|
+$1.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.29M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.74M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.76M |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$2.35M |
| 5 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
-$1.79M |
BLFS Hedge Fund Activity: Q1 2023 in Review
169 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2023, worth a combined $850M — up 23% from $690M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new BLFS positions and 13 closed out — a net gain of 7 holders — while 62 added to existing stakes and 48 trimmed.
The largest buyer was Park West Asset Management, adding an estimated $11.3M. The largest seller was Millennium Management, cutting an estimated $4.29M.
- 169 institutional investors held BioLife Solutions (BLFS) as of Q1 2023, up from 164 in Q4 2022.
- Funds reported $850M of BioLife Solutions stock for Q1 2023, up 23% quarter-over-quarter.
- 20 funds opened new BioLife Solutions positions in Q1 2023 and 13 closed out, a net change of +7 holders.
- The largest BioLife Solutions buyer in Q1 2023 was Park West Asset Management, an estimated $11.3M added.
- The largest BioLife Solutions seller in Q1 2023 was Millennium Management, an estimated $4.29M sold.
Based on aggregated 13F filings for Q1 2023.